Goodricke Group Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 2, 2025, 8:10 pm

Competitors of Goodricke Group Ltd

All Competitor Stocks of Goodricke Group Ltd

Quarterly Result

Last Updated: March 4, 2025, 12:11 am

Below is a detailed analysis of the quarterly data for Goodricke Group Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

• For Sales, as of Dec 2024, the value is ₹284.00 Cr.. The value appears to be declining and may need further review. It has decreased from 316.00 Cr. (Sep 2024) to ₹284.00 Cr., marking a decrease of 32.00 Cr..
• For Expenses, as of Dec 2024, the value is ₹297.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 250.00 Cr. (Sep 2024) to ₹297.00 Cr., marking an increase of 47.00 Cr..
• For Operating Profit, as of Dec 2024, the value is ₹-13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 66.00 Cr. (Sep 2024) to ₹-13.00 Cr., marking a decrease of 79.00 Cr..
• For OPM %, as of Dec 2024, the value is -4.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Sep 2024) to -4.00%, marking a decrease of 25.00%.
• For Other Income, as of Dec 2024, the value is ₹3.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 3.00 Cr..
• For Interest, as of Dec 2024, the value is ₹2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Sep 2024) to ₹2.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Dec 2024, the value is ₹5.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 5.00 Cr..
• For Profit before tax, as of Dec 2024, the value is ₹-17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Sep 2024) to ₹-17.00 Cr., marking a decrease of 78.00 Cr..
• For Tax %, as of Dec 2024, the value is -3.00%. The value appears to be improving (decreasing) as expected. It has decreased from 1.00% (Sep 2024) to -3.00%, marking a decrease of 4.00%.
• For Net Profit, as of Dec 2024, the value is ₹-16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Sep 2024) to ₹-16.00 Cr., marking a decrease of 76.00 Cr..
• For EPS in Rs, as of Dec 2024, the value is -7.47. The value appears to be declining and may need further review. It has decreased from 27.90 (Sep 2024) to -7.47, marking a decrease of 35.37.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: March 5, 2025, 5:38 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 2:37 pm

Below is a detailed analysis of the balance sheet data for Goodricke Group Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2024, the value is ₹22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 22.00 Cr..
• For Reserves, as of Sep 2024, the value is ₹292.00 Cr.. The value appears strong and on an upward trend. It has increased from 220.00 Cr. (Mar 2024) to ₹292.00 Cr., marking an increase of 72.00 Cr..
• For Borrowings, as of Sep 2024, the value is ₹135.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 126.00 Cr. (Mar 2024) to ₹135.00 Cr., marking an increase of 9.00 Cr..
• For Other Liabilities, as of Sep 2024, the value is ₹306.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 281.00 Cr. (Mar 2024) to ₹306.00 Cr., marking an increase of 25.00 Cr..
• For Total Liabilities, as of Sep 2024, the value is ₹755.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 648.00 Cr. (Mar 2024) to ₹755.00 Cr., marking an increase of 107.00 Cr..
• For Fixed Assets, as of Sep 2024, the value is ₹316.00 Cr.. The value appears to be declining and may need further review. It has decreased from 326.00 Cr. (Mar 2024) to ₹316.00 Cr., marking a decrease of 10.00 Cr..
• For CWIP, as of Sep 2024, the value is ₹29.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Mar 2024) to ₹29.00 Cr., marking an increase of 5.00 Cr..
• For Investments, as of Sep 2024, the value is ₹3.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to ₹3.00 Cr., marking an increase of 3.00 Cr..
• For Other Assets, as of Sep 2024, the value is ₹407.00 Cr.. The value appears strong and on an upward trend. It has increased from 298.00 Cr. (Mar 2024) to ₹407.00 Cr., marking an increase of 109.00 Cr..
• For Total Assets, as of Sep 2024, the value is ₹755.00 Cr.. The value appears strong and on an upward trend. It has increased from 648.00 Cr. (Mar 2024) to ₹755.00 Cr., marking an increase of 107.00 Cr..

Notably, the Reserves (₹292.00 Cr.) exceed the Borrowings (135.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Goodricke Group Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is -32.08. This value is below the healthy minimum of 5. It has decreased from -0.15 (Mar 23) to -32.08, marking a decrease of 31.93.
• For Diluted EPS (Rs.), as of Mar 24, the value is -32.08. This value is below the healthy minimum of 5. It has decreased from -0.15 (Mar 23) to -32.08, marking a decrease of 31.93.
• For Cash EPS (Rs.), as of Mar 24, the value is -22.51. This value is below the healthy minimum of 3. It has decreased from 9.38 (Mar 23) to -22.51, marking a decrease of 31.89.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 111.68. It has decreased from 143.93 (Mar 23) to 111.68, marking a decrease of 32.25.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 111.68. It has decreased from 143.93 (Mar 23) to 111.68, marking a decrease of 32.25.
• For Dividend / Share (Rs.), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 381.47. It has decreased from 408.42 (Mar 23) to 381.47, marking a decrease of 26.95.
• For PBDIT / Share (Rs.), as of Mar 24, the value is -16.13. This value is below the healthy minimum of 2. It has decreased from 13.25 (Mar 23) to -16.13, marking a decrease of 29.38.
• For PBIT / Share (Rs.), as of Mar 24, the value is -25.70. This value is below the healthy minimum of 0. It has decreased from 3.72 (Mar 23) to -25.70, marking a decrease of 29.42.
• For PBT / Share (Rs.), as of Mar 24, the value is -30.38. This value is below the healthy minimum of 0. It has decreased from 1.17 (Mar 23) to -30.38, marking a decrease of 31.55.
• For Net Profit / Share (Rs.), as of Mar 24, the value is -32.09. This value is below the healthy minimum of 2. It has decreased from -0.14 (Mar 23) to -32.09, marking a decrease of 31.95.
• For PBDIT Margin (%), as of Mar 24, the value is -4.22. This value is below the healthy minimum of 10. It has decreased from 3.24 (Mar 23) to -4.22, marking a decrease of 7.46.
• For PBIT Margin (%), as of Mar 24, the value is -6.73. This value is below the healthy minimum of 10. It has decreased from 0.91 (Mar 23) to -6.73, marking a decrease of 7.64.
• For PBT Margin (%), as of Mar 24, the value is -7.96. This value is below the healthy minimum of 10. It has decreased from 0.28 (Mar 23) to -7.96, marking a decrease of 8.24.
• For Net Profit Margin (%), as of Mar 24, the value is -8.41. This value is below the healthy minimum of 5. It has decreased from -0.03 (Mar 23) to -8.41, marking a decrease of 8.38.
• For Return on Networth / Equity (%), as of Mar 24, the value is -28.72. This value is below the healthy minimum of 15. It has decreased from -0.10 (Mar 23) to -28.72, marking a decrease of 28.62.
• For Return on Capital Employeed (%), as of Mar 24, the value is -15.14. This value is below the healthy minimum of 10. It has decreased from 1.88 (Mar 23) to -15.14, marking a decrease of 17.02.
• For Return On Assets (%), as of Mar 24, the value is -10.69. This value is below the healthy minimum of 5. It has decreased from -0.05 (Mar 23) to -10.69, marking a decrease of 10.64.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.06. This value is below the healthy minimum of 0.2. It has increased from 0.05 (Mar 23) to 0.06, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.47. This value is within the healthy range. It has increased from 0.18 (Mar 23) to 0.47, marking an increase of 0.29.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.28. It has decreased from 1.38 (Mar 23) to 1.28, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 24, the value is 1.00. This value is below the healthy minimum of 1.5. It has decreased from 1.26 (Mar 23) to 1.00, marking a decrease of 0.26.
• For Quick Ratio (X), as of Mar 24, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.56 (Mar 23) to 0.49, marking a decrease of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.48. This value is below the healthy minimum of 4. It has decreased from 1.61 (Mar 23) to 1.48, marking a decrease of 0.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is -3.45. This value is below the healthy minimum of 3. It has decreased from 5.20 (Mar 23) to -3.45, marking a decrease of 8.65.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -5.86. This value is below the healthy minimum of 3. It has decreased from 0.94 (Mar 23) to -5.86, marking a decrease of 6.80.
• For Enterprise Value (Cr.), as of Mar 24, the value is 450.25. It has increased from 397.36 (Mar 23) to 450.25, marking an increase of 52.89.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.54. This value is below the healthy minimum of 1. It has increased from 0.45 (Mar 23) to 0.54, marking an increase of 0.09.
• For EV / EBITDA (X), as of Mar 24, the value is -12.92. This value is below the healthy minimum of 5. It has decreased from 13.88 (Mar 23) to -12.92, marking a decrease of 26.80.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.42. This value is below the healthy minimum of 1. It has increased from 0.40 (Mar 23) to 0.42, marking an increase of 0.02.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 1.46. This value is within the healthy range. It has increased from 1.14 (Mar 23) to 1.46, marking an increase of 0.32.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.42. This value is below the healthy minimum of 1. It has increased from 0.40 (Mar 23) to 0.42, marking an increase of 0.02.
• For EarningsYield, as of Mar 24, the value is -0.19. This value is below the healthy minimum of 5. It has decreased from 0.00 (Mar 23) to -0.19, marking a decrease of 0.19.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness